RecallRadar

FDA Drug recall D-0840-2026

Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217…

On 2026-09-09 the FDA classified a Class III recall of Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217… by American Health Packaging, citing labeling: Label Mix-up.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0840-2026
ClassificationClass III
Statusongoing
Initiated2026-08-19
Published2026-09-09
Last updated2026-09-23 05:30 UTC
CompanyAmerican Health Packaging
DistributionUS

Product

Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).

Reason

Labeling: Label Mix-up

Identifiers

ndc60687-481-11
ndc60687-481-21
ndc60687-492-11
ndc60687-492-21
code_infoLot # 1030023, Exp Date: 06/30/2027.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-23 05:30 UTC. Current status: ongoing.

Other recalls by American Health Packaging

All American Health Packaging recalls

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0840-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.